NCT06773962 - A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 20, 2025

Primary Completion Date

December 29, 2025

Study Completion Date

December 29, 2025

Conditions

Parkinson's Disease (PD)

Interventions

DRUG

TB006

IV infusion.

DRUG

Placebo

IV infusion.

Trial Locations (11)

11772

RECRUITING

NYU Langone Health, Patchogue

33136

RECRUITING

University of Miami, Miami

33486

RECRUITING

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

33613

RECRUITING

University of South Florida Parkinson's and Movement Disorders Center, Tampa

46256

RECRUITING

Josephson Wallack Munshower Neurology - Southeast, Indianapolis

48334

RECRUITING

Quest Research Institute, Farmington Hills

60062

RECRUITING

Consultants in Neurology, Ltd, Northbrook

66160

RECRUITING

University of Kansas Medical Center, Kansas City

78681

RECRUITING

Central Texas Neurology Consultants, Round Rock

80113

RECRUITING

CenExel Rocky Mountain Clinical Research, Englewood

92656

RECRUITING

Parkinson's Research Centers of America - Orange County, Aliso Viejo

All Listed Sponsors

lead

TrueBinding, Inc.

INDUSTRY